ImaginAb aims to help our immune systems better detect late-stage cancer June 10, 2021 Categories: Health Care Tags: ImaginAb
ImaginAb completes $12.8 million financing to accelerate growth plans June 4, 2021 Categories: Health Care Tags: ImaginAb
ImaginAb News: ImaginAb and NEUVOGEN Announce Licensing Agreement for CD8 ImmunoPET Technology January 28, 2021 Categories: Uncategorized Tags: ImaginAb
ImaginAb News: Announces license and supply agreement with Pfizer for CD8 immunoPET technology January 7, 2021 Categories: Uncategorized Tags: ImaginAb
